US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT07105670 N/A
Recruiting
Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
Condition
Chronic Kidney Disease Stage 3
Enrollment
15 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06937866 Phase 1, Phase 2
Recruiting
Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Condition
Germ Cell Tumor
Enrollment
38 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT05386043 N/A
Recruiting
Registering Genomics and Imaging of Tumors (ReGIT)
Condition
Glioma
Enrollment
20 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT07287774 N/A
Recruiting
Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids
Condition
Hearing Loss, Cochlear
Enrollment
50 pts
Location
United States
Sponsor
Purdue University
View Trial →
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT04363684 N/A
Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Condition
Frontotemporal Lobar Degeneration (FTLD)
Enrollment
2,100 pts
Location
United States, Canada
Sponsor
Mayo Clinic
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT04781140 Phase 4
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Chi...
Condition
Attention-Deficit/Hyperactivity Disorder
Enrollment
286 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT02397668 N/A
Recruiting
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Condition
Tricuspid Valve Disease
Enrollment
78 pts
Location
United States
Sponsor
Corvivo Cardiovascular, Inc.
View Trial →
NCT04817618 Phase 3
Recruiting
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Condition
C3G
Enrollment
98 pts
Location
United States, Argentina, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07155187 Phase 2, Phase 3
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (...
Condition
Non-Small Cell Lung Cancer
Enrollment
490 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
View Trial →
NCT07362017 Phase 3
Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate...
Condition
Moderate-to-severe Chronic Plaque Psoriasis
Enrollment
300 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
304 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
View Trial →
NCT05237258 N/A
Recruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute...
Condition
Relapsed Adult AML
Enrollment
2,300 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT06541886 N/A
Recruiting
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
Condition
Insomnia
Enrollment
28 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT05200923 N/A
Recruiting
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Condition
Overactive Bladder
Enrollment
300 pts
Location
United States
Sponsor
MedtronicNeuro
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07355062 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Me...
Condition
CKD
Enrollment
150 pts
Location
United States
Sponsor
Renibus Therapeutics, Inc.
View Trial →
NCT06001827 N/A
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Condition
Chronic Kidney Diseases
Enrollment
600 pts
Location
United States
Sponsor
VenoStent
View Trial →
NCT03876054 N/A
Recruiting
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Condition
Chronic Pain
Enrollment
2,000 pts
Location
United States, Australia, Belgium
Sponsor
Abbott Medical Devices
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT05108090 N/A
Recruiting
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and...
Condition
Squamous Cell Carcinoma
Enrollment
94 pts
Location
United States
Sponsor
Indiana University
View Trial →
Page 4 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology